Skip to main content

Table 4 Comparison of SNP data acquired either by sequencing or DNA microarray technology.

From: A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs

  

1st wash

2nd wash

 

SNP

Country

κ

n

%

κ

n

%

Agreement

CYP2A6*2

Cambodia

0.87

24

88.9

0.92

19

70.4

Substantial to almost

 

Tanzania

0.83

58

82.9

0.61

53

75.7

perfect

CYP2B6*5

Cambodia

0.94

27

100.0

0.94

27

100.0

Almost perfect

 

Tanzania

0.92

67

95.7

0.86

67

95.7

 

CYP2B6*6

Cambodia

0.42

26

96.3

0.42

27

100.0

Fair to moderate

 

Tanzania

0.35

63

90.0

0.40

59

84.3

 

CYP2C8*3

Cambodia

0.97

20

74.1

1.00

20

74.1

Substantial to almost

 

Tanzania

0.90

39

55.7

0.79

38

54.3

perfect

CYP2C9*3

Cambodia

0.92

26

96.3

0.94

26

96.3

Almost perfect

 

Tanzania

0.90

67

95.7

0.82

64

91.4

 

CYP2C9*5

Cambodia

0.98

27

100.0

1.00

27

100.0

Almost perfect

 

Tanzania

0.93

67

95.7

0.86

70

100.0

 

CYP2C19*3

Cambodia

1.00

27

100.0

1.00

26

96.3

Almost perfect

 

Tanzania

0.90

97

95.7

0.83

66

94.3

 

CYP2D6*4

Cambodia

0.98

26

96.3

1.00

26

96.3

Almost perfect

 

Tanzania

0.91

63

90.0

0.88

65

92.9

 

CYP2D6*10 (100C>T)

Cambodia

0.59

24

88.9

0.64

20

74.1

Moderate to substantial

 

Tanzania

0.72

31

44.3

0.76

27

38.6

 

CYP2D6*10 (4180G>C)

Cambodia

0,40

21

77.8

0.50

17

63.0

Fair to moderate

 

Tanzania

0.45

45

64.3

0.51

38

54.3

 

CYP2D6*17 (1023C>T)

Cambodia

0.86

19

70.4

1.00

6

22.2

Moderate to almost

 

Tanzania

0.59

37

52.9

0.49

37

52.9

perfect

CYP2D6*17 (2850C>T)

Cambodia

0.29

7

25.9

0.20

6

22.2

Slight to substantial

 

Tanzania

0.66

20

28.6

0.59

21

30.0

 

CYP3A4*1B

Cambodia

0.00

6

22.2

0.00

5

18.5

Slight to substantial

 

Tanzania

0.76

23

32.9

0.69

22

31.4

 

CYP3A5*3

Cambodia

0.39

21

77.8

0.42

17

63

Fair to substantial

 

Tanzania

0.73

61

87.1

0.65

58

82.9

 

NAT2*5

Cambodia

0.32

14

51.9

0.38

8

29.6

Fair to moderate

 

Tanzania

0.47

37

52.9

0.53

28

40.0

 

NAT2*6

Cambodia

0.70

26

96.3

0.73

25

92.6

Substantial

 

Tanzania

0.74

62

88.6

0.71

62

88.6

 

NAT2*7

Cambodia

0.72

25

92.6

0.70

22

81.5

Substantial

 

Tanzania

0.75

55

78.6

0.67

49

70.0

 

NAT2*14

Cambodia

1.00

27

100.0

1.00

27

100.0

Substantial to almost

 

Tanzania

0.76

62

88.6

0.74

61

87.1

perfect

  1. Data was acquired in 27 Cambodian and 70 Tanzanian malaria patients. κ indicates the kappa index. n is the number and % the percentage of samples with results for both techniques.